SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc. – ‘10-K’ for 12/31/20 – ‘EX-23.1’

On:  Monday, 3/1/21, at 4:02pm ET   ·   For:  12/31/20   ·   Accession #:  731766-21-13   ·   File #:  1-10864

Previous ‘10-K’:  ‘10-K’ on 2/14/20 for 12/31/19   ·   Next:  ‘10-K’ on 2/15/22 for 12/31/21   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/01/21  Unitedhealth Group Inc.           10-K       12/31/20  107:17M

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.87M 
 2: EX-10.11    Material Contract                                   HTML    189K 
 3: EX-10.12    Material Contract                                   HTML     35K 
 4: EX-10.32    Material Contract                                   HTML     72K 
 5: EX-21.1     Subsidiaries List                                   HTML    314K 
 6: EX-23.1     Consent of Expert or Counsel                        HTML     29K 
 7: EX-24.1     Power of Attorney                                   HTML     34K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     38K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     31K 
16: R1          Cover Document                                      HTML     94K 
17: R2          Consolidated Balance Sheets                         HTML    150K 
18: R3          Consolidated Balance Sheet (Parenthetical)          HTML     53K 
19: R4          Consolidated Statements of Operations               HTML    113K 
20: R5          Consolidated Statements of Comprehensive Income     HTML     75K 
21: R6          Consolidated Statements of Changes in Equity        HTML    107K 
22: R7          Consolidated Statement of Changes in Equity         HTML     31K 
                (Parentheticals)                                                 
23: R8          Consolidated Statements of Cash Flows               HTML    120K 
24: R9          Description of Business (Notes)                     HTML     29K 
25: R10         Basis of Presentation, Uses of Estimates and        HTML     76K 
                Significant Accounting Policies (Notes)                          
26: R11         Investments (Notes)                                 HTML    143K 
27: R12         Fair Value (Notes)                                  HTML    110K 
28: R13         Property, Plant, and Capitalized Software (Notes)   HTML     45K 
29: R14         Goodwill and Intangible Assets (Notes)              HTML     88K 
30: R15         Medical Costs Payable (Notes)                       HTML     61K 
31: R16         Short-Term Borrowings and Long-Term Debt (Notes)    HTML    186K 
32: R17         Income Taxes (Notes)                                HTML    118K 
33: R18         Shareholders' Equity (Notes)                        HTML     49K 
34: R19         Share-Based Compensation (Notes)                    HTML     81K 
35: R20         Commitments and Contingencies (Notes)               HTML     46K 
36: R21         Business Combinations Business Combinations         HTML     39K 
                (Notes)                                                          
37: R22         Segment Financial Information (Notes)               HTML    217K 
38: R23         Schedule I (Notes)                                  HTML    142K 
39: R24         Basis of Presentation, Uses of Estimates and        HTML    122K 
                Significant Accounting Policies (Policies)                       
40: R25         Fair Value Fair Value (Policies)                    HTML     41K 
41: R26         Schedule I (Policies)                               HTML     95K 
42: R27         Basis of Presentation, Uses of Estimates and        HTML     58K 
                Significant Accounting Policies (Tables)                         
43: R28         Investments (Tables)                                HTML    142K 
44: R29         Fair Value (Tables)                                 HTML    103K 
45: R30         Property, Plant, and Capitalized Software (Tables)  HTML     44K 
46: R31         Goodwill and Intangible Assets (Tables)             HTML     95K 
47: R32         Medical Costs Payable (Tables)                      HTML     64K 
48: R33         Short-Term Borrowings and Long-Term Debt (Tables)   HTML    188K 
49: R34         Income Taxes (Tables)                               HTML    121K 
50: R35         Shareholders' Equity (Tables)                       HTML     50K 
51: R36         Share-Based Compensation (Tables)                   HTML     86K 
52: R37         Commitments and Contingencies (Tables)              HTML     39K 
53: R38         Business Combinations Business Combinations         HTML     36K 
                (Tables)                                                         
54: R39         Segment Financial Information (Tables)              HTML    205K 
55: R40         Schedule I (Tables)                                 HTML    144K 
56: R41         Basis of Presentation, Uses of Estimates and        HTML     75K 
                Significant Accounting Policies (Details)                        
57: R42         Basis of Presentation, Uses of Estimates and        HTML     41K 
                Significant Accounting Policies Useful lives for                 
                property, equipment and capitalized software                     
                (Details)                                                        
58: R43         Basis of Presentation, Uses of Estimates and        HTML     50K 
                Significant Accounting Policies Redeemable                       
                Noncontrolling Interests (Details)                               
59: R44         Investments (Narrative) (Details)                   HTML     39K 
60: R45         Investments (Short-Term and Long-Term Investments)  HTML     80K 
                (Details)                                                        
61: R46         Investments (Amortized Cost and Fair Value of       HTML     98K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
62: R47         Investments (Fair Value of Available-For-Sale       HTML     64K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
63: R48         Fair Value (Narrative) (Details)                    HTML     37K 
64: R49         Fair Value (Financial Assets and Liabilities,       HTML     86K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
65: R50         Fair Value (Financial Assets and Liabilities, Not   HTML     54K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
66: R51         Property, Plant, and Capitalized Software           HTML     33K 
                (Narrative) (Details)                                            
67: R52         Property, Plant, and Capitalized Software Property  HTML     51K 
                Plant and Equipment Table (Details)                              
68: R53         Goodwill and Intangible Assets (Narrative)          HTML     31K 
                (Details)                                                        
69: R54         Goodwill and Intangible Assets Changes in the       HTML     49K 
                Carrying Amount of Goodwill by Reporting Segment                 
                (Details)                                                        
70: R55         Goodwill and Intangible Assets Gross carrying       HTML     47K 
                value, accumulated amortization and net carrying                 
                value of intangible assets (Details)                             
71: R56         Goodwill and Intangible Assets Weighted-average     HTML     41K 
                useful lives assigned to finite-lived intangible                 
                assets acquired in business combinations (Details)               
72: R57         Goodwill and Intangible Assets Amortization         HTML     40K 
                Expense relating to Intangible Assets (Details)                  
73: R58         Medical Costs Payable (Narrative) (Details)         HTML     29K 
74: R59         Medical Costs Payable Rollforward (Details)         HTML     51K 
75: R60         Medical Costs Payable, Incurred and Paid Medical    HTML     42K 
                Cost Development (Details)                                       
76: R61         Short-Term Borrowings and Long-Term Debt            HTML     62K 
                (Narrative) (Details)                                            
77: R62         Short-Term Borrowings and Long-Term Debt (Details)  HTML    212K 
78: R63         Short-Term Borrowings and Long-Term Debt            HTML     44K 
                Maturities of commercial paper and long-term debt                
                (Details)                                                        
79: R64         Income Taxes (Narrative) (Details)                  HTML     61K 
80: R65         Income Taxes Reconciliation of Provision for        HTML     47K 
                Income Taxes (Details)                                           
81: R66         Income Tax Reconciliation of the tax provision at   HTML     68K 
                the U.S. Federal Statutory Rate (Details)                        
82: R67         Income Taxes Components of Deferred Tax Assets and  HTML     78K 
                Liabilities (Details)                                            
83: R68         Income Taxes Reconciliation of the beginning and    HTML     43K 
                ending amount of unrecognized tax benefits                       
                (Details)                                                        
84: R69         Shareholders' Equity (Narrative) (Details)          HTML     40K 
85: R70         Shareholders' Equity Share Repurchases (Details)    HTML     38K 
86: R71         Shareholders' Equity Dividends (Details)            HTML     33K 
87: R72         Share-Based Compensation (Narrative) (Details)      HTML     38K 
88: R73         Share-Based Compensation (Stock Option Activity)    HTML     74K 
                (Details)                                                        
89: R74         Share-Based Compensation (Restricted Share          HTML     46K 
                Activity) (Details)                                              
90: R75         Share-Based Compensation Other Share-Based          HTML     59K 
                Compensation Data (Details)                                      
91: R76         Share-Based Compensation (Share-Based Compensation  HTML     54K 
                Principal Fair Value Assumptions) (Details)                      
92: R77         Commitments and Contingencies (Narrative)           HTML     51K 
                (Details)                                                        
93: R78         Commitments and Contingencies Future Lease          HTML     52K 
                Payments (Details)                                               
94: R79         Business Combinations Acquired Assets and           HTML     46K 
                Liabilities (Details)                                            
95: R80         Business Combinations (Narrative) (Details)         HTML     37K 
96: R81         Segment Financial Information (Narrative)           HTML     43K 
                (Details)                                                        
97: R82         Segment Financial Information (Details)             HTML    127K 
98: R83         Schedule I (Details)                                HTML     42K 
99: R84         Schedule I Condensed Balance Sheets (Details)       HTML    112K 
100: R85         Schedule I Balance Sheet Document (Details)         HTML     48K  
101: R86         Schedule I Condensed Statement of Comprehensive     HTML     79K  
                Income (Details)                                                 
102: R87         Schedule I Statement of Cash Flows (Details)        HTML     92K  
103: R88         Schedule I Maturities of Short-Term Borrowings and  HTML     48K  
                Long-Term Debt (Details)                                         
105: XML         IDEA XML File -- Filing Summary                      XML    197K  
15: XML         XBRL Instance -- unh-20201231_htm                    XML   4.75M 
104: EXCEL       IDEA Workbook of Financial Reports                  XLSX    157K  
11: EX-101.CAL  XBRL Calculations -- unh-20201231_cal                XML    309K 
12: EX-101.DEF  XBRL Definitions -- unh-20201231_def                 XML   1.41M 
13: EX-101.LAB  XBRL Labels -- unh-20201231_lab                      XML   2.42M 
14: EX-101.PRE  XBRL Presentations -- unh-20201231_pre               XML   1.67M 
10: EX-101.SCH  XBRL Schema -- unh-20201231                          XSD    224K 
106: JSON        XBRL Instance as JSON Data -- MetaLinks              552±   841K  
107: ZIP         XBRL Zipped Folder -- 0000731766-21-000013-xbrl      Zip    711K  


‘EX-23.1’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-236600 on Form S-3, No. 333-105877 on Form S-4, Nos. 333-174436, 333-174437, 333-193962, 333-205824, 333-205826, 333-221642, 333-224253, 333-224254, 333-234018, 333-236349 and 333-238854 on Form S-8 and Post-Effective Amendment on Form S-8 to Registration Statement File No. 333-216153 on Form S-4 of our reports dated March 1, 2021, relating to the consolidated financial statements and financial statement schedules of UnitedHealth Group Incorporated and Subsidiaries, and the effectiveness of UnitedHealth Group Incorporated and Subsidiaries' internal control over financial reporting, appearing in this Annual Report on Form 10-K of UnitedHealth Group Incorporated for the year ended December 31, 2020.
/S/ DELOITTE & TOUCHE LLP
Minneapolis, Minnesota
March 1, 2021



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/1/21
For Period end:12/31/2011-K
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/24/23  UnitedHealth Group Inc.           10-K       12/31/22  119:19M
 2/15/22  UnitedHealth Group Inc.           10-K       12/31/21  113:19M
10/29/21  UnitedHealth Group Inc.           S-8        10/29/21    5:264K
10/29/21  UnitedHealth Group Inc.           S-8        10/29/21    4:175K
 5/18/21  UnitedHealth Group Inc.           424B5                  1:435K                                   Donnelley … Solutions/FA
 5/17/21  UnitedHealth Group Inc.           424B5                  1:407K                                   Donnelley … Solutions/FA


24 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/21  UnitedHealth Group Inc.           8-K:5,9     2/22/21   13:376K
 2/08/21  UnitedHealth Group Inc.           8-K:5,9     2/02/21   13:285K
 8/03/20  UnitedHealth Group Inc.           10-Q        6/30/20   56:13M
 6/01/20  UnitedHealth Group Inc.           S-8         6/01/20    5:292K
 2/14/20  UnitedHealth Group Inc.           10-K       12/31/19  112:20M
11/07/17  UnitedHealth Group Inc.           10-Q        9/30/17   58:9.9M
 3/27/17  UnitedHealth Group Inc.           S-8 POS     3/27/17    6:341K                                   Donnelley … Solutions/FA
 2/15/17  UnitedHealth Group Inc.           S-8 POS     2/15/17    5:264K                                   Donnelley … Solutions/FA
 8/02/16  UnitedHealth Group Inc.           10-Q        6/30/16   60:10M
11/05/15  UnitedHealth Group Inc.           10-Q        9/30/15   84:13M
 7/23/15  UnitedHealth Group Inc.           S-8         7/23/15    6:462K
 7/01/15  UnitedHealth Group Inc.           8-K:1,3,5,9 7/01/15    2:138K
 7/01/15  UnitedHealth Group Inc.           8-A12B/A               3:192K
 6/15/15  Advisory Board Co.                8-K:5,9     6/09/15    5:305K                                   Donnelley … Solutions/FA
 5/06/15  UnitedHealth Group Inc.           10-Q        3/31/15   66:14M
 2/07/13  Unitedhealth Group Inc.           10-K       12/31/12  114:25M
11/03/10  Unitedhealth Group Inc.           10-Q        9/30/10   83:13M                                    Donnelley … Solutions/FA
 2/10/10  Unitedhealth Group Inc.           10-K       12/31/09   42:5.4M                                   Donnelley … Solutions/FA
 2/11/09  Unitedhealth Group Inc.           10-K       12/31/08   29:2.8M                                   Donnelley … Solutions/FA
 2/04/08  Unitedhealth Group Inc.           S-3ASR      2/04/08    9:842K                                   Donnelley … Solutions/FA
 8/06/07  Unitedhealth Group Inc.           10-Q        6/30/07    8:917K                                   Donnelley … Solutions/FA
11/17/05  Advisory Board Co.                8-K:1,9    11/15/05    2:87K                                    Donnelley Fi… Express/FA
11/13/01  Unitedhealth Group Inc.           10-Q        9/30/01    4:254K                                   Toppan Merrill-FA2/FA
 1/11/99  Unitedhealth Group Inc.           S-3/A                 30:1.5M                                   Donnelley … Solutions/FA
Top
Filing Submission 0000731766-21-000013   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 5:33:03.4pm ET